Dr. rer. nat. Kornelia Eichelbaum



  • Kamprath K, Bieberbach A, Hinkelmann K. Patent Term Extension in Europe – SPCs for Combination Products [in Japanese]. Journal of the Japanese Group of AIPPI.
    2012 Feb; Vol. 57, No. 2;
  • Riebe CJ, Pamplona FA, Kamprath K, Wotjak CT. Fear relief – toward a new conceptual frame work and what endocannabinoids gotta do with it. Neuroscience.
    2012 Mar 1;204:159-85;
  • Kamprath K, Romo-Parra H, Häring M, Gaburro S, Doengi M, Lutz B, Pape HC. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology.
    2011 Feb;36(3):652-63;
  • Kamprath K, Plendl W, Marsicano G, Deussing JM, Wurst W, Lutz B, Wotjak CT. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain Behav. 2009
  • Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci.
    2006 Jun 21;26(25):6677-86;
  • Kamprath K, Wotjak CT. Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learn Mem.
    2004 Nov-Dec;11(6):770-86;
  • Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn Mem.
    2004 Sep-Oct;11(5):625-32;
  • Jacobs EH, Spijker S, Verhoog CW, Kamprath K, de Vries TJ, Smit AB, Schoffelmeer AN. Active heroin administration induces specific genomic responses in the nucleus accumbens shell. FASEB J.
    2002 Dec;16(14):1961-3.


Patent Attorney

European Trade Mark
and Design Attorney

European Patent Attorney